CME Group Inc. Files 8-K on Financials

Ticker: CME · Form: 8-K · Filed: 2025-07-23T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: CME

TL;DR

CME Group filed an 8-K on 7/23/25 detailing financial condition. No major news yet.

AI Summary

On July 23, 2025, CME Group Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.

Why It Matters

This filing provides an update on CME Group's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K filing?

The filing indicates it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific details are not provided in the excerpt.

When was this 8-K report filed?

The report was filed on July 23, 2025.

What is the principal business address of CME Group Inc.?

The principal executive office is located at 20 South Wacker Drive, Chicago, Illinois, 60606.

What is CME Group Inc.'s Commission File Number?

CME Group Inc.'s Commission File Number is 001-31553.

What is the IRS Employer Identification Number for CME Group Inc.?

The IRS Employer Identification Number for CME Group Inc. is 36-4459170.

From the Filing

0001156375-25-000176.txt : 20250723 0001156375-25-000176.hdr.sgml : 20250723 20250723070845 ACCESSION NUMBER: 0001156375-25-000176 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250723 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250723 DATE AS OF CHANGE: 20250723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 09 Crypto Assets EIN: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 251141606 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 cme-20250723.htm 8-K cme-20250723 false 0001156375 0001156375 2025-07-23 2025-07-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   _________________________________________________________ FORM 8-K   _________________________________________________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 23, 2025     _________________________________________________________ CME GROUP INC. (Exact Name of Registrant as Specified in its Charter)   _________________________________________________________   Delaware   001-31553   36-4459170 (State or Other Jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)   20 South Wacker Drive Chicago Illinois   60606 (Address of Principal Executive Offices)   (Zip Code) Registrant’s telephone number, including area code: ( 312 )  930-1000 N/A (Former Name or Former Address, if Changed Since Last Report)   ______________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock CME Nasdaq Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02. Results of Operations and Financial Condition. The information set forth under “Item 2.02. Results Of Operations and Financial Condition,” including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as s

View on Read The Filing